No Data
No Data
HKEX Stock Market Live | Ec Healthcare (02138) fell more than 6%, leading the decline in the medical beauty concept. The demand for medical beauty is temporarily under pressure, and the growth in the second quarter is slightly under pressure.
Aesthetic medicine stocks collectively declined, as of press time, ec healthcare (02138) fell by 5.45%, at HKD 1.04; shanghai haohai biological technology (06826) fell by 4.56%, at HKD 30.35; sisram med (01696) fell by 3.69%, at HKD 3.13.
HTSC: Different performance for beauty and medical beauty in Q2. Q3 may be more challenging for new product sales during off-season.
In Q3 24, it is the off-season for the industry, but also an important window period for many brand manufacturers to prepare for the November 11 shopping festival. It is recommended to pay close attention to new product developments.
Hong Kong's pharmaceutical stocks rebounded today! After a deep adjustment from the beginning of the year until now, can they achieve a bottom-up rebound?
Since 2024, innovative drugs have received a variety of benefits from the policy combination. From multi-dimensional support for speeding up the registration and evaluation of innovative drugs, promoting multi-tiered innovation, and reasonable pricing of new drugs, the policy has moved from 'encouraging large-scale innovation' to 'encouraging high-quality innovation'.
Who will benefit from the major adjustment in the Hong Kong Stock Connect in September?
While mainland China is increasingly valuing the Hong Kong stock market, policies are also releasing more bullish news regarding the Hong Kong Stock Connect.
BOC International: Continued prosperity of upstream medical beauty manufacturers opens up space for external expansion.
According to the research reports released by BOC International, the performance of leading medical and aesthetic companies is still maintaining good growth, and the average product price has not shown any price reduction pressure. The constantly enriched product matrix is expected to bring growth in the future.
Has the peak of summer medical beauty consumption been flattened out? Behind the market diversion, the performance of institutions may be further divided|Industry observation
Is the trend of flattening the peak of summer medical beauty significantly? Recently, Caixin reporters visited several medical beauty institutions that were supposed to be in the "peak sales period" and did not find a "booming" phenomenon.
No Data